BPW
PFE icon

Bingham Private Wealth’s Pfizer PFE Stock Holding History

Bingham Private Wealth’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$453K Buy
18,802
+322
+2% +$8.42K 0.31% 93
2026
Q1 		$519K Buy
18,480
+4,800
+35% +$128K 0.41% 75
2025
Q4 		$341K Buy
+13,680
New +$345K 0.29% 102
2025
Q2 		$343K Sell
14,152
-547
-4% -$12.8K 0.33% 95
2025
Q1 		$372K Buy
14,699
+4,592
+45% +$120K 0.39% 85
2024
Q4 		$268K Buy
+10,107
New +$274K 0.29% 111

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Bingham Private Wealth's PFE Position: Q2 2026 in Review

Bingham Private Wealth increased its Pfizer (PFE) stake by 1.7% in Q2 2026, buying an estimated $8.42K and bringing the position to 18,802 shares worth $453K. The position accounts for 0.31% of the portfolio, ranked #93.

Bingham Private Wealth first reported a position in PFE in Q4 2024 and has held it in 6 quarters since. The position peaked at $519K in Q1 2026. 2,831 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Bingham Private Wealth held 18,802 shares of Pfizer worth $453K as of Q2 2026.
  • Bingham Private Wealth bought 322 Pfizer shares in Q2 2026, an estimated $8.42K.
  • Pfizer made up 0.31% of Bingham Private Wealth's portfolio in Q2 2026, its #93 holding.
  • Bingham Private Wealth first reported a position in Pfizer in Q4 2024 and has held it in 6 quarters since.
  • Bingham Private Wealth's Pfizer position peaked at $519K in Q1 2026.
  • 2,831 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Bingham Private Wealth's 13F filing for Q2 2026, filed 11 Aug 2026.